How big is the IVF time-lapse imaging devices market?

The market size of IVF time-lapse imaging devices in 2027 is calculated to be USD 888.99 million.

How is the IVF time-lapse imaging devices industry expected to grow over the next 10 years?

IVF Time-lapse Imaging Devices Market size was more than USD 747.3 million in 2026 and is set to grow at a 22.52% CAGR between 2027 and 2036, reaching USD 5.7 billion by 2036.

How is AI-driven embryo selection influencing adoption of time-lapse imaging systems in IVF clinics?

AI-enabled embryo assessment is increasing adoption by transforming time-lapse imaging into a decision-support tool. Clinics invest in these systems to improve selection consistency, reduce subjectivity, and strengthen treatment outcomes through continuous embryo monitoring data.

How are fertility preservation and delayed parenthood trends expanding demand for IVF time-lapse imaging devices?

Delayed parenthood and rising fertility preservation programs are increasing IVF cycles and long-term clinic engagement. This expands demand for advanced imaging systems that support consistent embryo monitoring and optimize outcomes across increasingly complex patient profiles.

Why do hospitals and other settings dominate the IVF time-lapse imaging devices market?

Hospitals & Other Settings accounted for 73.92% of the market in 2026, supported by established embryology workflows, centralized laboratory resources, and broader procedural capacity for assisted reproductive services.

Which end-use segment is expanding the fastest in the IVF time-lapse imaging devices market?

Fertility Clinics are the fastest-growing segment because their specialized embryo monitoring and IVF treatment workflows enable quicker adoption of time-lapse imaging technologies that support core fertility services.

What factors make Europe the leading market for IVF time-lapse imaging devices?

Europe accounted for 38.27% of the market in 2026, supported by established fertility care infrastructure, widespread use of embryo monitoring technologies, and routine integration into IVF laboratory workflows.

Why is Asia Pacific experiencing the fastest growth in the IVF time-lapse imaging devices market?

Asia Pacific is expected to expand at a 25.3% CAGR as fertility clinics upgrade laboratory capabilities, adopt advanced embryo monitoring systems, and expand treatment capacity across growing clinic networks.

Who are the major participants shaping the IVF time-lapse imaging devices landscape?

Major companies in the IVF time-lapse imaging devices market include Vitrolife AB (Sweden), Esco Medical Technologies UAB (Lithuania), Genea Biomedx Pty Ltd. (Australia), ASTEC Co., Ltd. (Japan), Merck KGaA (Germany), FUJIFILM Irvine Scientific, Inc. (United States), CooperSurgical, Inc. (United States), Hamilton Thorne Ltd. (Canada).